Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Gambling.com IPO: 7 Things for Potential GAMB Stock Investors to Know

Today's Gambling.com IPO didn't go as many investors had hoped, with shares of GAMB stock trading down in the afternoon.

TAL, GOTU, EDU: Why Are Chinese Stocks Down Today?

Today, Chinese stocks are plummeting as the Chinese government announced further market interventions that investors are viewing negatively.

CCIV Stock: 7 Things for Churchill Capital Investors to Know Following Today’s Lucid Vote

Today, CCIV stock is down on news that the shareholder vote on the company's business combination with Lucid Motors has been delayed.

JPM Stock: A Look at the 5 Crypto Funds JPMorgan Will Now Allow Its Clients to Trade

Today, JPM stock is little-moved on an announcement that this major U.S. bank will begin allowing retail investors to buy crypto shortly.

IPA Stock: 7 Things to Know About Covid Vaccine Stock ImmunoPrecise as Shares Rocket 120%

Today's impressive move in ImmunoPrecise's stock price has led investors in IPA stock to consider what is driving these price changes.